Anders LonningSkovgaard - Coloplast A/S President
| CLPBF Stock | USD 128.57 7.42 6.12% |
President
Mr. Anders LonningSkovgaard was Chief Financial Officer, Executive Vice President and Member of the Executive Management at Coloplast AS since July 1, 2014. Since joining the Company in 2006, Anders has held a commercial management position and most recently been SVP for Corporationrationrate IT. He holds a MS degree from the School of Business and Social Sciences at Aarhus Universitet . since 2014.
| Age | 51 |
| Tenure | 10 years |
| Phone | 45 49 11 11 11 |
| Web | https://www.coloplast.com |
Coloplast A/S Management Efficiency
The company has return on total asset (ROA) of 0.1714 % which means that it generated a profit of $0.1714 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7507 %, meaning that it generated $0.7507 on every $100 dollars invested by stockholders. Coloplast A/S's management efficiency ratios could be used to measure how well Coloplast A/S manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Alberto Mas | Becton Dickinson and | 59 | |
| Alain Morvan | Coloplast A | N/A | |
| Simon Campion | Becton Dickinson and | 49 | |
| Nicolai Andersen | Coloplast A | 54 | |
| Roland Goette | Becton Dickinson and | 58 | |
| Thomas Spoerel | Becton Dickinson and | 45 | |
| Patrick Kaltenbach | Becton Dickinson and | 56 | |
| Samrat Khichi | Becton Dickinson and | 53 | |
| James Borzi | Becton Dickinson and | 49 | |
| Christopher Reidy | Becton Dickinson and | 64 | |
| Alexandre Conroy | Becton Dickinson and | 57 | |
| David Hickey | Becton Dickinson and | 60 | |
| Betty Larson | Becton Dickinson and | 44 | |
| Charles Bodner | Becton Dickinson and | 46 | |
| John DeFord | Becton Dickinson and | 55 | |
| Christopher DelOrefice | Becton Dickinson and | 53 | |
| Guillaume Daniellot | Straumann Holding AG | 53 | |
| James Lim | Becton Dickinson and | 56 | |
| Paul Marcun | Coloplast A | 56 | |
Management Performance
| Return On Equity | 0.75 | |||
| Return On Asset | 0.17 |
Coloplast A/S Leadership Team
Elected by the shareholders, the Coloplast A/S's board of directors comprises two types of representatives: Coloplast A/S inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Coloplast. The board's role is to monitor Coloplast A/S's management team and ensure that shareholders' interests are well served. Coloplast A/S's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Coloplast A/S's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ellen Bjurgert, VP Relations | ||
| Allan Rasmussen, Executive VP of Global Operations | ||
| Alain Morvan, Senior Vice President Sales Europe | ||
| Thomas Barfod, Director, Employee Representative | ||
| Nicolai Andersen, Senior Vice President Wound Care | ||
| Anders LonningSkovgaard, CFO, Executive Vice President Member of the Executive Management | ||
| Kristian Villumsen, Executive VP of Chronic Care | ||
| Paul Marcun, Senior Vice President Emerging Markets | ||
| Dorthe Ronnau, VP Culture | ||
| Dennis Kaysen, Director Communications |
Coloplast Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Coloplast A/S a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.75 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 28.84 B | |||
| Shares Outstanding | 194.31 M | |||
| Shares Owned By Insiders | 35.00 % | |||
| Shares Owned By Institutions | 25.53 % | |||
| Price To Earning | 37.47 X | |||
| Price To Book | 22.60 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Coloplast Pink Sheet
Coloplast A/S financial ratios help investors to determine whether Coloplast Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast A/S security.